Scinovex
articleTop 10% cited

Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients

Breast Cancer Research and Treatment · 2007 · Vol. 111(1) · pp. 27–44
David S.P. TanCaterina MarchiòRobin L. JonesKay SavageIan E. SmithMitch DowsettJorge S. Reis‐Filho
Breast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchAdvanced Breast Cancer TherapiesAnthracyclineBreast cancerOncologyMedicineAdjuvantInternal medicineCancerProfiling (computer programming)

MeSH terms

Antineoplastic AgentsBreast NeoplasmsFemaleHumansImmunohistochemistryPhenotypePrognosisBiomarkers, TumorChemotherapy, AdjuvantIn Situ HybridizationAnthracyclinesTissue Array AnalysisKaplan-Meier Estimate

Funding

  • Associazione Italiana per la Ricerca sul Cancro
Citations
319
FWCI
12.42
field-weighted impact
References
62
Percentile
99%
vs. same field & year
Citations per year
Cited by
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.